Cryo-EM market seen reaching $3.23 billion by 2030

The cryo-electron microscopy market is projected to nearly double from 2025 to 2030 as drug development, infectious disease research and automation drive demand. North America leads now, while Asia-Pacific is expected to grow fastest.

Why it matters: - Cryo-electron microscopy is becoming a more important tool for drug discovery, structural biology and infectious disease research. - The market’s growth reflects rising demand from pharmaceutical, biotechnology and research organizations for higher-resolution imaging. - The expansion to $3.23 billion by 2030 signals a larger commercial base for microscope makers, software providers and sample-prep technology vendors.

What happened: - The cryo-electron microscopy market was valued at $1.69 billion in 2025 and is projected to reach $1.93 billion in 2026. - The market is forecast to grow to $3.23 billion by 2030. - The Business Research Company published the outlook on Aug. 3, 2026. - North America held the largest market share in 2025. - Asia-Pacific is projected to be the fastest-growing region through the forecast period.

The details: - The report pegs 2025-2026 growth at a 14.2% compound annual growth rate. - The 2026-2030 forecast implies a 13.7% CAGR. - Early market growth was supported by academic adoption, research activity in life sciences and structural biology, and demand despite high instrument costs and limited microscope availability. - The report links future growth to automated imaging and data acquisition, pharmaceutical and biotechnology investment, and broader use in cell and gene therapy research. - Contract research organizations, higher-resolution detectors and cameras, and more advanced 3D reconstruction software are also expected to add momentum. - The report highlights wider use of fully automated cryo-electron microscopes, single particle analysis, cryo-electron tomography and improved sample-prep and detector technologies as key trends. - Cryo-EM uses rapid freezing to preserve biological samples without stains or crystallization, enabling near-atomic-resolution imaging of complex molecules. - The method helps researchers study molecular structure, interactions and mechanisms in their near-native state. - Infectious disease research is a major demand driver because cryo-EM can visualize viruses, bacteria and host-pathogen interactions at high resolution. - CDC data cited in the report showed US tuberculosis cases rose from 8,320 in 2022 to 9,615 in 2023.

Between the lines: - The forecast points to a market moving from early adoption toward broader industrial use. - Automation appears to be the main lever for growth, since it can ease sample-preparation bottlenecks and improve throughput. - The regional split suggests North America remains the research leader, while Asia-Pacific is gaining ground through biotech expansion and government support. - The infectious-disease backdrop gives the market a practical public-health tailwind beyond basic research demand.

What's next: - More companies are likely to invest in automated microscopes, advanced detectors and 3D reconstruction software. - Pharmaceutical and biotech spending on drug development and therapy research should remain a core demand source. - Adoption in Asia-Pacific is likely to accelerate as emerging economies expand advanced research capacity. - The report also points to rising use by contract research organizations, which could widen access to cryo-EM services.

The bottom line: - Cryo-electron microscopy is shifting from a specialized research tool to a faster-growing platform with broader commercial and biomedical uses.